Short answer · Medically reviewed summary · Last updated: 2026-05-08
Mixed Connective Tissue Disease (MCTD) is classified under the ICD-10 code M35.1 (Other overlap syndromes), while the legacy ICD-9 code is 710.8. Because Mixed Connective Tissue Disease features overlapping symptoms of systemic lupus erythematosus, scleroderma, and polymyositis, clinicians often use these specific codes to capture the multisystem nature of the diagnosis. What exactly is Mixed Connective Tissue Disease? Mixed Connective Tissue Disease is a rare autoimmune disorder where the immune system mistakenly attacks the body’s own healthy tissues.
1 people with Mixed Connective Tissue Disease (MCTD) have shared their first-person experience on this question at DiseaseMaps.
Mixed Connective Tissue Disease (MCTD) is classified under the ICD-10 code M35.1 (Other overlap syndromes), while the legacy ICD-9 code is 710.8. Because Mixed Connective Tissue Disease features overlapping symptoms of systemic lupus erythematosus, scleroderma, and polymyositis, clinicians often use these specific codes to capture the multisystem nature of the diagnosis.
Mixed Connective Tissue Disease is a rare autoimmune disorder where the immune system mistakenly attacks the body’s own healthy tissues. Patients with Mixed Connective Tissue Disease often present with high titers of anti-U1 ribonucleoprotein (RNP) antibodies. Because it affects various systems—including the circulatory, respiratory, and musculoskeletal systems—it requires a coordinated approach by a rheumatologist to manage symptoms effectively.
Diagnosis relies on a combination of clinical criteria and serological testing. There is no single "gold standard" test, but physicians typically look for the following indicators:
While there is no cure for Mixed Connective Tissue Disease, current treatment protocols focus on suppressing immune activity to prevent organ damage. Many patients, like those in our 273-member DiseaseMaps community, utilize medications such as methotrexate for disease-modifying control and prednisone to manage acute inflammatory flares. Consistent monitoring of lung and heart function is essential due to the multisystem impact of the disease.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding any medical condition.